Key statistics
As of last trade Adaptive Biotechnologies Corp (1HM:FRA) traded at 13.12, -25.90% below its 52-week high of 17.71, set on Nov 25, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 13.12 |
|---|---|
| High | 13.12 |
| Low | 13.12 |
| Bid | 13.15 |
| Offer | 13.28 |
| Previous close | 13.12 |
| Average volume | 549.44 |
|---|---|
| Shares outstanding | 153.78m |
| Free float | 150.63m |
| P/E (TTM) | -- |
| Market cap | 2.44bn USD |
| EPS (TTM) | -0.3987 USD |
Data delayed at least 15 minutes, as of Feb 10 2026 07:04 GMT.
More ▼
Announcements
- Adaptive Biotechnologies Reports Fourth Quarter and Full Year 2025 Financial Results
- Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
- Adaptive Biotechnologies to Report Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
- Adaptive Biotechnologies Announces Preliminary Fourth Quarter and Full Year 2025 Results
- Adaptive Biotechnologies to Present at the 44th Annual J.P. Morgan Healthcare Conference
- Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer
- Adaptive Biotechnologies to Participate in Jefferies Fireside Chat Series on Minimal Residual Disease
- Adaptive Biotechnologies Showcases Leadership in Hematology-Oncology MRD with New clonoSEQ® Data Driving Treatment Interventions at 2025 ASH Annual Meeting
- Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting
- Adaptive Biotechnologies to Participate in Upcoming Investor Conferences
More ▼
